A Message from The Chief
The Division of Hematology and Oncology represents the specialties of medical oncology, hematology (benign and malignant) and bone marrow and stem cell transplantation (BSCMT) and is an integral part of Sylvester Comprehensive Cancer Center (SCCC) with its outpatient facilities throughout South Florida including clinics at Coral Springs, Deerfield Beach, Hollywood , Plantation and Kendall. Additionally our faculty provides inpatient and outpatient services University of Miami Hospital and Clinics (UMHC), University of Miami Hospital (UMH), the Miami Veterans Administration Hospital (VA) and Jackson Memorial Hospital (JMH) are served by our faculty. The Divisional faculty include clinician –educators, clinical researchers, and basic scientists with an interest in cancer and hematologic diseases. Faculty are members of formal scientific programs at the University of Miami Sylvester Comprehensive Cancer Center and figure prominently in cancer center scientific efforts. Many of the faculty are internationally recognized for their expertise in clinical care, and for their efforts in clinical, basic, and translational research. Over 150 active clinical therapeutic trials are being conducted by our faculty including investigator initiated , cooperative group and pharmaceutically supported trials, including Phase I, II and III trials, providing patients from within and outside the region with novel clinical options. Extensive extramurally funded basic and translational research is ongoing within the division.Many of the faculty are nationally recognized experts in their areas of interest, participate in state of the art clinical trials and publish widely in outstanding journals. Dedicated medical staff, e.g. advanced registered nurse practitioners (ARNP), physician assistants (PA), registered oncology nurses (RN), and administrative staff, lend support to our ongoing clinical effort in a multi-disciplinary milieu. State of the art multidisciplinary care is delivered by our faculty to cancer patients with hematologic malignancies and solid tumors, and to patients with non-malignant hematologic disorders within formally organized multi-disciplinary Site Disease groups. A highly selective nationally regarded Hematology-Oncology fellowship training program is ACGME accredited. Many of our matriculated fellows hold prominent academic appointments at outstanding domestic and international institutions.
Our patients are referred to experts in specialized clinics including but not limited to breast cancer, lung cancer, head and neck cancer, gastrointestinal malignancies, genitourinary malignancies, hematologic malignancies including leukemia, myeloma and lymphoma, malignant melanoma, sarcomas and other rare tumors, and/or to hematologists with expertise in the care and management of benign hematologic diseases such as thrombotic disorders, myeloproliferative diseases, coagulopathies and or hemoglobinopathies. In addition our bone marrow and stem cell transplantation team will see patients with a variety of indications for autologous , allogeneic or cord blood stem cell transplantation and represents the only regional program of its type. Patients requiring systemic therapy, are treated in our outpatient facility: comprehensive treatment unit (CTU) which operates 7 days a week at the UM Sylvester Comprehensive Cancer Center, and at satellite infusion clinics at Deerfield, Kendall, Hollywood and Plantation locations, and/or as inpatients at our affiliated hospitals. Dedicated staff including oncology nursing, pharmacists, and other supportive and administrative staff provide service at all locations.
The Division encourages you to learn more about our innovative clinical services , research and education programs.
Joseph D. Rosenblatt, M.D.
Chief, Division of Hematology-Oncology, Department of Medicine
Professor of Medicine, Microbiology & Immunology
William J. Harrington Chair in Hematology